As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback